title: Durban--between the lines.
abstract: This year's XIIIth International AIDS Conference in Durban, South Africa was not the typical AIDS conference. Because of the pressing social needs faced by developing nations, the emphasis of the meeting was not primarily directed toward biomedical research and studies. Instead, the main topics of discussion included human rights, reducing the stigma faced by people living with HIV, prevention, vaccine research, access to care, reduced drug pricing and building medical and social infrastructure. Still, medical research was not ignored. This issue of PI Perspective represents a summary of some of the most significant findings presented at the conference. Topics include anti-HIV research, treatment interruption studies, women-specific issues, side effect warnings and the first ever report on the medical use of marijuana in people with HIV.
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000600:supply & distribution / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D013019:South Africa
chemical_list: D019380:Anti-HIV Agents